Diabetes mellitus is a major health concern in current scenario which has been found
to affect people of almost all ages. The disease has huge impact on global health;
therefore, alternate methods apart from insulin injection are being explored to cure
diabetes. Therefore, this review mainly focuses on the current status and therapeutic
potential of stem cells mainly mesenchymal stem cells (MSCs) for Type 1 diabetes mellitus
in preclinical animal models as well as humans.